Lifting of federal rulemaking freeze linked to HR 9 enactment in Rep. McIntosh subcommittee mark-up.
Executive Summary
LIFTING OF FEDERAL RULEMAKING FREEZE TIED TO HR 9 ENACTMENT under an amendment offered by Rep. Ehrlich (R-Md.) and approved by the House Government Reform/National Economic Growth Subcommittee at a Feb. 8 mark-up of "The Regulatory Transition Act of 1995" (HR 450). The amendment extends the expiration date of the proposed federal regulatory moratorium until the enactment of regulatory reform. The deadline for lifting the rulemaking freeze was July 1, 1995 in the original bill.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth